Novo Nordisk Working On Even Better Weight Loss Drugs
May 9, 2024 Novo Nordisk is beginning work on a follow-up weight loss medicine that would last longer and could be manufactured more easily. On
How GLP-1 Drugs Are Changing The Weight Loss Market – Podcast
May 9, 2024 John LaRosa, Marketdata’s Research Director and founder, was recently interviewed by Kimberly Adams at Marketplace, a business and economic program, along with
Weight Watchers Reports Q1 Results
May 2, 2024 Management reported that: “We delivered solid performance in the first quarter with end of period subscribers of 4.0 million, improved retention and
Medifast Reports Q1 2024 Results
April 29, 2024 Management said that: “Our new model is highly differentiated from competitors, with a holistic approach including our habit-based and Coach guided solution
Higher Quality Weight Loss Drugs Coming in the Future
April 29, 2024 According to an article at Biospace.com, GLP-1 agonists are set to become the best-selling drugs in 2024, but the biopharma industry isn’t
Telehealth Weight Loss Market Worth $6.9 Billion And Growing
April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for
Oprah’s TV Special Falls Short
March 19, 2024 Last night Oprah Winfrey hosted a TV special investigating the popular GLP-1 diet drugs. The stories by people who lost significant weight
Eli Lilly Offers Access To Zepbound via Amazon
March 14, 2024 The U.S. pharmaceutical giant Eli Lilly is partnering with Amazon to help distribute its prescription drugs, notably its new weight loss treatment